This Week In Huntington's Disease Research keeps you up-to-date on HDSA research activities, recently published work about Huntington’s disease, historical moments in HD research and more.

Happy Holidays from HDSA

Posted on December 23, 2021

Through all the challenges 2021 had in store, the resilience of the HD community has continued to inspire HDSA in our…

Read More

uniQure opens new study sites and changes inclusion criteria for AMT-130 trial

Posted on December 16, 2021

In a press release published this morning, uniQure announced that AMT-130, an investigational gene therapy for treatment of Huntington’s disease,…

Read More

A new Biomarker for HD: HDBuzz on radiolabels for mHTT

Posted on December 9, 2021

A research team led by Dr. Celia Dominguez at CHDI has identified a new method to track the presence of…

Read More

Mark Your Calendars: “Ask the Scientists … Anything” HDSA Research Webinar

Posted on December 2, 2021

As November chill slowly turns to December cold, mark your calendars for HDSA’s final research webinar of the year on Tuesday, December 7th. Three editors…

Read More

Now Accepting Applications for 2022 Berman-Topper and Donald A. King Research Fellowships

Posted on November 18, 2021

Earlier this week on November 16, HDSA launched applications for the 2022 cycles of its prestigious Berman-Topper Family HD Career…

Read More

Webinar TODAY! Take Action and Support the HD Parity Act

Posted on November 11, 2021

We talk a lot about what we’re hopeful for tomorrow here in the research world, and it’s equally important to…

Read More

Research Wrap-Up: HDBuzz Covers EHDN’s Annual Research Conference

Posted on November 4, 2021

In September, the European Huntington’s Disease Network brought together scientists and stakeholders from around the world for updates from experts in…

Read More

HDSA Research Webinar 11/3/21: Register TODAY!

Posted on October 28, 2021

Dr. Jane Paulsen will join HDSA next week to discuss a new observational trial, PREVENT-HD, Preparing for the Prevention of Huntington’s…

Read More

Prilenia Therapeutics and HSG announce completion of participant enrollment in PROOF-HD

Posted on October 21, 2021

In a recent press release, Prilenia Therapeutics and the Huntington’s Study Group (HSG) announced the completion of participant enrollment in PROOF-HD,…

Read More

HDSA Awards Five Huntington’s Disease Human Biology Project Research Grants

Posted on October 14, 2021

After thoughtful deliberation by its Scientific Advisory Board, HDSA will award five the Huntington’s Disease Human Biology Project research grants to Joan O’Keefe,…

Read More

Dr. Francis S. Collins to Step Down from Head of NIH

Posted on October 7, 2021

On Tuesday of this week, Francis S. Collins, MD, PhD, announced he would step down from his role as Director of the…

Read More

HD Buzz: Real talk with Roche on GENERATION-HD1

Posted on September 30, 2021

The editors of HD Buzz recently sat down with leaders from Roche to ask questions on behalf of the HD community…

Read More

HDSA Research Webinar TODAY!

Posted on September 23, 2021

Join HDSA TODAY at 12PM (ET) for the next HDSA Research Webinar! HDSA Human Biology Project Fellows Dr. Michael Placzek (Massachusetts General…

Read More

Roche Regroups: New Partnerships forged in HD Research

Posted on September 16, 2021

After an unexpected dosing halt in the GENERATION-HD1 study nearly 6 months ago, Roche is gearing up to increase their…

Read More

Wave Life Sciences begins SELECT-HD Trial

Posted on September 9, 2021

Wave Life Sciences shared a press release this morning announcing that dosing has begun in the SELECT-HD trial. The study…

Read More

Advances in Gene Therapy: HDBuzz Covers Exciting New Regulatory System, Xon

Posted on September 2, 2021

Researchers at the Children’s Hospital of Philadelphia have created a system to better regulate gene editing by administration of a secondary activator drug. This novel system, dubbed Xon, acts…

Read More

KINECT-HD2: Rollover Study of Valbenazine for Chorea in HD

Posted on August 26, 2021

KINECT-HD2, the open-label extension of KINECT-HD, is seeking 30 new participants to join a study of valbenazine for chorea in Huntington’s disease….

Read More

HDBuzz on Recent News in the HD Research Pipeline

Posted on August 19, 2021

The August 9th press release from Voyager Therapeutics left many of us scratching our heads. Luckily, HDBuzz swooped in with their latest…

Read More

Voyager Therapeutics Shifts Directions

Posted on August 12, 2021

Voyager Therapeutics issued a press release on Monday about their finances, recent leadership transitions, and importantly, a major shift in their…

Read More

HD Parity Act and Pro-Patient Advocacy in the Neurological Disease Community

Posted on August 5, 2021

Last week, Kala Booth, a Huntington’s disease patient, caregiver, advocate, and the 4th known generation in her family to test HD positive appeared before the House…

Read More